LabReflex
GRAIL Galleri Test Advances at FDA; PAMA Cuts Threaten Lab Margins
21:52
GRAIL Galleri Test Advances at FDA; PAMA Cuts Threaten Lab Margins
In this episode, we discuss two major developments affecting laboratory medicine: GRAIL's Galleri multi-cancer early detection test moving closer to FDA approval, and proposed Medicare reimbursement cuts that could significantly impact clinical laboratories.
We begin with the FDA advisory committee's recent review of Galleri,…